PFE · News · 20260822N
Depo-Provera Litigation Settlement
PFIZER INC · 2026-08-22 · Importance 58 · Surprise 42 · In source text
Pfizer agreed to a confidential settlement program covering plaintiffs’ Depo-Provera meningioma lawsuits. The program could involve more than US$1.20 billion in compensation, making it a material legal and cash-flow exposure. The settlement may reduce uncertainty around the litigation, although the reporting states that broader drug-pricing reforms could continue to pressure Pfizer’s long-term pricing and margins.
Key facts
- Pfizer has agreed to a confidential settlement program with plaintiffs for Depo-Provera meningioma lawsuits potentially involving over US$1.20 billion in compensation. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | committed | — | Pfizer has agreed to a confidential settlement program with plaintiffs for Depo-Provera meningioma lawsuits potentially involving over… |